Loading…
the sparker alert will let you know when a significant move starts with an audio alert, so You'll never miss an Opportunity.
Achieve Life Sciences Inc Is A Late-Stage Specialty Pharmaceutical Company Focused On The World-Wide Development And Commercialization Of Cytisinicline As A Treatment For Nicotine Dependence. Its New Drug Application (Nda) For Cytisinicline For Smoking Cessation In Adults Is Supported By Two Completed Phase 3 Studies And An Open-Label Long-Term Safety Study. It Has Also Completed A Phase 2 Study Of Cytisinicline In Nicotine E-Cigarette Cessation, Conducted An End-Of-Phase 2 Meeting With The Fda, And Has Received Breakthrough Therapy Designation For The Vaping Cessation Indication.